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Rho and basic fibroblast growth factor
involvement in centrosome redistribution and
actin microfilament remodeling during early
endothelial wound repair
Tsu-Yee Joseph Lee, PhD, and Avrum I. Gotlieb, MD, Toronto, Ontario, Canada
Objective: We have shown that centrosome redistribution to the front of the cell and actin microfilament remodeling
occurs during the initiation of early porcine aortic endothelial wound repair even before cell migration. Because Ras
homologous protein (Rho) induces actin microfilament polymerization, interacts with microtubules, and is believed to be
activated by growth factors, we set forth to study the regulatory roles of basic fibroblast growth factor (bFGF) and Rho
signaling on centrosome redistribution and actin microfilament remodeling in endothelial cells at an in vitro wound edge.
Study Design: With double immunofluorescent confocal microscopy, we studied the distribution of various cytoskeletal
proteins in wounded porcine aortic endothelial cells in response to bFGF and exoenzyme C3 treatments.
Results: We showed that the addition of 10 ng/mL bFGF for 3 hours after wounding resulted in a significant increase
(P < .05) in cells at the wound edge with central microfilaments oriented perpendicular to the wound. Rho inhibition
with 2g/mL C3 resulted in the reduction of phosphotyrosine, paxillin, and central microfilament staining. Centrosome
redistribution and endothelial cell elongation also were significantly inhibited (P < .05) with C3, resulting in decreased
wound closure. However, inhibition was reduced with coincubation of bFGF with C3, which also returned the rate of
endothelial wound closure toward control values. This Rho-independent bFGF-induced centrosome redistribution was
associated with the cells showing a significant increase (P < .05) in acetylated microtubules that extended from the
centrosome to the posterior cell border.
Conclusion: We conclude that Rho regulates centrosome redistribution and central microfilament remodeling during early
endothelial wound repair, and bFGF promotes actin remodeling through a downstream Rho-dependent pathway and
promotes centrosome redistribution, at least in part, with a Rho-independent pathway. (J Vasc Surg 2002;35:1242-52.)
The loss of endothelial integrity caused by denudation
occurs at sites of enhanced endothelial turnover, which are
predisposed to atherosclerosis, on ulcerated atherosclerotic
plaques, and with therapeutic interventions, such as angio-
plasty and coronary artery bypass graft surgery. The endo-
thelial cell is able to respond to denudation by switching
from a resting cell designed for barrier function to an
activated cell that promotes cell migration and prolifera-
tion1 and thus rapidly repairs the wounded vessel.
Maintenance of endothelial structural integrity involves
the microtubule and actin cytoskeleton.2 Within a conflu-
ent monolayer, actin microfilaments are distributed at the
cell periphery known as the dense peripheral band (DPB)
and centrally known as central microfilaments (or stress
fibers). The DPB is important in cell-cell adhesion, whereas
central microfilaments are important in cell-substratum
adhesion.3
Endothelial cells at the wound edge undergo three
sequential stages of actin microfilament remodeling to be-
come migrating cells.3 After wounding, endothelial cells at
the wound edge enter stage I (0 to 2 hours after wounding)
of early repair, characterized by the breakdown of the DPB
and the presence of a few randomly oriented central micro-
filaments. The cells then enter stage II (2 to 4 hours),
characterized by central microfilaments oriented parallel to
the wound edge. The cells then enter stage III (6 to 8
hours), characterized by central microfilaments perpendic-
ular to the wound edge and by the initiation of cell migra-
tion. Tyrosine phosphorylation and dephosphorylation at
cell-substratum and cell-cell adhesion sites are important
for microfilament remodeling.4 Basic fibroblast growth
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factor (bFGF) enhances progression through the three stages,
associated with the earlier appearance of prominent central
microfilaments oriented perpendicular to the wound edge.5
Although central microfilaments are important in early
repair, they are not essential. Instead, endothelial repair and
wound closure is a microtubule-dependent event linked to
centrosome polarization.6 After a denuding wound before
the onset of cell migration, randomly oriented centrosomes
at the wound edge undergo redistribution to the front of
the cell towards the wound6 and if inhibited, repair takes
five times longer.7 Redistribution is dependent on intact
microtubules6 and requires the presence of bFGF8 but does
not require the presence of intact microfilament bundles.6
The mechanisms that regulate repair and the associated
centrosome redistribution and actin central microfilament
remodeling remain unclear. The hypothesis studied was
that bFGF regulated early actin microfilament and micro-
tubule cytoskeletal events through a Rho-dependent path-
way during early repair. Rho proteins belong to the Rho
subfamily of the p21 Ras superfamily of small guanosine
triphosphate binding proteins and can be activated by
guanine nucleotide exchange factors (GEFS) or inactivated
by guanosine triphosphatase-activating proteins.9 Activa-
tion is regulated by thrombin/bombesin,10,11 bacterial
toxins,12 lysophosphatidic acid,13 and growth factors.10,14
The bacterial exoenzyme C3 is an adenosine diphosphate-
ribosyltransferase that selectively modifies Rho at aspara-
gine 41 in its effector region causing Rho inactivation.12
Rho has been implicated in actin stress fiber polymeriza-
tion, focal adhesion formation,10,13 and in microtubule
stabilization.15 In addition, Rho is important in endothelial
migration16 and barrier function.17,18
MATERIALS AND METHODS
Cell culture. Endothelial cells were harvested from
slaughterhouse porcine aortas with collagenase enzyme
dispersion and cultured in medium M199 supplemented
with 5% fetal bovine serum, 50 U/mL penicillin, 50
g/mL streptomycin sulfate, and 0.25 g/mL Fungizone
(M199  5% fetal bovine serum  1% penicillin strepto-
mycin sulfate fungizone) as described.6 Cells from passages
3 to 7 were used.
Wounding. Cells were seeded on 22 22-mm sterile
glass coverslips (Corning, New York, NY) in 35-mm tissue
culture dishes (Nunc, Burlington, Ontario, Canada). Three
days after the cultures reached confluency, a single 1.0-mm
to 1.5-mm linear wound was made with a cell scraper down
the middle of the monolayer, creating a double-sided
wound.6 In selected experiments, the extent of wound
closure at 48 hours after wounding was determined.4 Ex-
periments were performed at least in triplicate.
Basic fibroblast growth factor and exoenzyme C3
treatments. Ten or 15 ng/mL exogenous human recom-
binant bFGF (UBI, Lake Placid, NY) or 2 g/mL purified
Clostridium botulinum exoenzyme C3 (UBI) or both were
prepared per manufacturer’s instructions immediately be-
fore use in standard media. bFGF was added immediately
after wounding, and C3 was added 24 hours before wound-
ing and immediately after wounding. Control cultures were
incubated with standard media alone. Control and experi-
mental treatments groups (2 g/mL C3, 10 ng/mL
bFGF, 2 g/mL C3  10 ng/mL bFGF, and 2 g/mL
C3 15 ng/mL bFGF) were fixed 3 hours after wounding
to determine cytoskeletal and cell length changes. This time
point was chosen because both stage II of repair and
centrosome redistribution are well developed.
Immunofluorescent staining and laser confocal mi-
croscopy. Confluent and wounded cultures were fixed and
double-stained 3 hours after wounding to localize F-actin,
-tubulin, phosphotyrosine, paxillin, RhoA, and acetylated
-tubulin. Cells were fixed for 10 minutes with 3% parafor-
maldehyde, prewarmed to 37° C, incubated with 0.2%
Triton X-100 for 5 minutes, and incubated for 30 minutes
with either anti- tubulin mouse monoclonal antibody
(1:400 dilution; Sigma Chemical Company, St Louis, Mo),
antiphosphotyrosine mouse monoclonal antibody (1:75;
ICN Biochemicals Inc, Costa Mesa, Calif), antipaxillin
mouse monoclonal antibody (1:75; Transduction Labora-
tories, Lexington, Ky), anti-RhoA rabbit polyclonal anti-
body (1:75; Santa Cruz Biotechnology Inc, Santa Cruz,
Calif), or antiacetylated tubulin mouse monoclonal anti-
body (1:150; Sigma Chemical Company). The cells then
were incubated for 30 minutes with a mixture of either
oregon green 488 goat antimouse immunoglobulin G
(IgG; HL) conjugate (1:200; Molecular Probes, Eugene,
Ore) with rhodamine-labeled phalloidin (1:30; Molecular
Probes) or with Cy3 goat antirabbit IgG (HL) conjugate
(1:150; Jackson ImmunoResearch Laboratories Inc, West
Grove, Mass). The coverslips were washed with phosphate-
buffered saline solution between each of the previous steps.
Controls were stained with the appropriate species IgG and
secondary antibodies. The coverslips were mounted with
Prolong Antifade (Molecular Probes). Cells were examined
with a BioRad MRC 1024ES scanning confocal laser im-
aging system (BioRad, Toronto, Ontario, Canada).4
Analysis of central microfilament remodeling, cen-
trosome redistribution, and acetylated -tubulin. Ori-
entations of actin central microfilaments were classified as
“parallel” or “perpendicular” relative to the wound edge as
described3 or as “lost” if central microfilaments were ab-
sent. Two hundred cells were examined per slide for each
group.
The centrosome was observed with staining for -tu-
bulin, and its location was determined with the nucleus and
the wound edge as reference points as described.6 Centro-
somes were identified as being “toward,” “middle,” or
“away” with respect to the nucleus and the front of the cell
in relation to the wound edge. Toward was located be-
tween the nucleus and the wound edge, and away was
located between the nucleus and the side of the cell facing
away from the wound. Middle was located along the side of
the nucleus. Two hundred cells were examined per slide for
each group.
The presence of stable microtubules was determined
with delineation of acetylated -tubulin processes extend-
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ing from the centrosome to the posterior cell border. Two
hundred cells were examined per slide for each group.
Analysis of cell length. Cell length along both wound
edges was measured with the basic image analysis software
supplied with the confocal imaging system. The length of
60 randomly selected cells were measured per slide for each
group described previously.
Statistical analysis. Factorial analysis of variance was
used to assess significance of microfilament remodeling,
centrosome redistribution, and cell length measurements.
If a significant difference was seen, then Fisher protected
least significant difference post hoc test was used to identify
significantly differing means. A P value of less than .05 was
considered significant. Statistical analysis was performed
with the Statview 4.5 program for Macintosh (Abacus
Concepts Inc, Cary, NC).
RESULTS
Effects of basic fibroblast growth factor and C3 on
central microfilament remodeling. Cells at the wound
edge were studied 3 hours after wounding when the cells
had progressed through stage I and entered stage II of early
repair. bFGF 10 ng/mL caused a significant decrease in the
percentage of cells at the wound edge with central micro-
filaments parallel to the wound edge (60.3% 1.2% of cells
for 10 ng/mL bFGF versus 65.6%  1.3% of cells for
control) and a significant increase in the percentage of cells
with central microfilaments perpendicular to the wound
edge (39.7%  1.2% of cells for 10 ng/mL bFGF versus
33.3%  1.7% of cells for control) when compared with
control (Figs 1, A, and 2, A,B). Thus, 10 ng/mL bFGF
accelerated the progression of endothelial cells at the
wound edge to stage III of early repair.
Addition of the Rho inhibitor C3, 2 g/mL, resulted
in significant loss of central microfilaments and actin-based
lamellipodia extrusions in most cells at the wound edge
(Fig 2, C). This was associated with decreased cell elonga-
tion, decreased lamellipodia extrusions, and gaps or cell
retractions between neighboring cells. The loss of central
microfilaments was limited only to cells at the wound edge
and a few rows back. This may be the result of a scrape-
loading effect or of the activation of quiescent cells at the
wound edge. Cells at the wound edge that still had recog-
nizable central microfilaments were assessed for their mi-
crofilament orientation. C3 caused a significant decrease in
the percentage of cells with central microfilaments parallel
to the wound edge (15.4%  0.7% of cells for 2 g/mL C3
versus 65.6%  1.3% of cells for control) and central micro-
filaments perpendicular to the wound edge (11.9% 0.4% of
cells for 2g/mL C3 versus 33.3%1.7% of cells for control)
when compared with control cultures (Fig 1, A).
Coincubation studies with bFGF and C3 were per-
formed to study the role of Rho on bFGF-induced effects.
The effects of 2 g/mL C3 on central microfilament loss
and orientation were not reversible with the coincubation
of 10 or 15 ng/mL bFGF (Figs 1, A, and 2, D). However,
a significant increase was seen in cell length at the wound
edge (Fig 2, D), suggesting that bFGF-induced endothelial
cell elongation may not be dependent on microfilaments.
Effects of C3 on phosphotyrosine and paxillin lo-
calization. Paxillin and tyrosine phosphorylation at focal
adhesion sites play an important role in early endothelial
wound repair.4 To determine whether Rho inhibition af-
fected signaling and focal adhesion complexes, the effects
of 2 g/mL C3 treatment on phosphotyrosine and paxillin
localization were investigated (Fig 3). A concomitant re-
duction of phosphotyrosine (Fig 3, C) and paxillin (Fig 3,
D) staining were observed with the loss of central micro-
filaments, such that the normal localization of phosphoty-
rosine (Fig 3, A) and paxillin (Fig 3, B) at the ends of
central microfilaments was not seen. However, phosphoty-
rosine was still seen at the tips of filopodia (Fig 3, C).
Effects of basic fibroblast growth factor and C3 on
endothelial elongation and wound closure. Cell lengths
were measured at the wound edge 3 hours after wounding to
determine whether the cytoskeletal effects induced with bFGF
and C3 altered cell elongation. Ten ng/mL bFGF did not
significantly enhance cell elongation when compared with
control cultures. Addition of 2 g/mL C3 showed a signifi-
cant decrease in cell length compared with either control or 10
ng/mL bFGF-treated cultures (54.4  1 m for 2 g/mL
C3 versus 61.9  2.2 m for control versus 64.7  0.8 m
for 10 ng/mL bFGF). Inhibition of cell elongation caused by
C3 treatment was reversed with the addition of 10 or 15
ng/mL bFGF, such that cells at the wound edge coincubated
together with bFGF and C3 were able to restore their cell
lengths back to control lengths (63.2  1.4 m for 10
ng/mL bFGF  C3 versus 61.7  2 m for 15 ng/mL
bFGF C3 versus 61.9 2.2 m for control).
To determine the relevance of the previous bFGF res-
cue of C3-treated cultures, we extended our studies to
examine wound closure. At 48 hours after wounding,
wound closure in cultures with both 10 ng/mL bFGF and
2 g/mL C3 was significantly greater than in 2 g/mL
Summary of Key Findings of C3 Treatment and bFGF/C3 cotreatments in wound Edge Endothelial
Cells.1  Increased;2  Decreased.
Exoenzyme C3 bFGF  exoenzyme C3
Tyrosine phosphorylation and perpendicular
central micro (stage III)
2 2
Centrosomal redistribution toward front of cell 2 1
Acetylated -tubulin centrosomal Processes 2 1
Cell length 2 1
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C3-treated cultures alone (97.24%  2.8% closure for
bFGF  C3 versus 89%  3.2% closure for C3 alone).
Effects of basic fibroblast growth factor and C3 on
centrosome redistribution. Centrosome redistribution
in response to bFGF and C3 treatments was studied 3 hours
after wounding. Addition of 10 ng/mL bFGF did not signif-
icantly increase centrosome redistribution towards the wound
when compared with control cultures, nor was any significant
difference seen in centrosome redistribution to the middle of
the cell or away from the wound edge (Fig 1, B).
However, 2 g/mL C3-treated cultures significantly
decreased the percentage of cells at the wound edge with
centrosome redistribution towards the wound (49.4% 
1.2% of cells for 2 g/mL C3 versus 56.5% 4.2% of cells
for control) and significantly increased the percentage of
cells with centrosome redistribution to the middle of the
cell (34.3% 1.2% of cells for 2g/mL C3 versus 25.9%
3.4% of cells for control) when compared with control (Fig
1, B). Thus, Rho inhibition reduced centrosome redistri-
bution from the middle of the cell to the front of the cell
Fig 1. Percentage of cells at wound edge with specific microfilament orientation (A) or specific centrosome position
(B) in response to exogenous bFGF or exoenzyme C3 3 hours after wounding. bFGF 10 ng/mL significantly decreased
percentage of cells exhibiting central microfilaments parallel to wound edge and significantly increased percentage of
cells exhibiting central microfilaments perpendicular to wound edge as compared with control (A). C3 2 g/mL
caused significant central microfilament loss (A) and significantly decreased centrosome distribution towards wound
(B) as compared with control. Coincubation of 10 or 15 ng/mL bFGF with 2 g/mL C3 did not reverse C3-induced
central microfilament loss (A) but did restore centrosome distribution towards wound back to control values.
Differences in central microfilament orientation or in centrosome position between control and treatment groups were
significant at *P  .05.
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towards the wound. C3 treatment resulted in intact but less
defined and slightly fragmented microtubules (Figs 4 and 5).
Cultures coincubated with 10 or 15 ng/mL bFGF and
2 g/mL C3 showed no significant difference in all three
centrosome positions as compared with either control or 10
ng/mL bFGF-treated cultures alone. Thus, bFGF reversed
C3 inhibition of centrosome redistribution.
RhoA and centrosome localization. In the confluent
monolayer, RhoA was concentrated at the centrosome and
localized alongside some microtubules in a punctate pattern
(Fig 5, A). Three hours after wounding in wound edge cells,
RhoA was again concentrated with the redistributed centro-
some and microtubules but was also seen in areas free of
microtubules (Fig 5, B). RhoA localized alongside some mi-
crotubules that radiated outwards from the centrosome to the
periphery (Fig 5, B). Colocalization of RhoA along the entire
length of microtubules was not seen as indicated by the
absence of yellow signal (indicating colocalization). In wound
edge cells treated with 10 ng/mL bFGF, RhoA and microtu-
bule staining were similar to controls (data not shown).
In wound edge cells treated with 2 g/mL C3 (Fig 5,
C) or with 10 ng/mL bFGF and 2 g/mL C3 (Fig 5, D),
RhoA staining was similar to control. The microtubule
cytoskeleton was less defined and slightly fragmented (Fig
5, C). C3 also resulted in less RhoA staining in cytoplasmic
areas free of polymerized microtubules (Fig 5, C; arrow) as
compared with control (Fig 5, B). RhoA also was seen in
areas of the cytoplasm that had highly disrupted microtu-
bules (Fig 5, C; arrowhead).
Effects of basic fibroblast growth factor and C3 on
stable acetylated -tubulin. To investigate the mecha-
nism of bFGF-induced centrosome redistribution via a
Rho-independent pathway, we examined the effects of
bFGF and C3 on the acetylation and subsequent stabiliza-
Fig 2. Confocal photomicrographs of control (A), bFGF-treated (B), C3-treated (C), or bFGF with C3-treated (D)
endothelial cells at wound edge 3 hours after wounding double-stained for F-actin and -tubulin. Wound is at top. A,
Control cells had central microfilaments parallel to wound edge. B, bFGF-treated (10 ng/mL) cells exhibited central
microfilaments perpendicular to wound edge. C, C3-treated (2 g/mL) cells had severe central microfilament loss,
decreased cell lengths, reduced lamellipodia extrusions, and lateral gaps between adjacent cells. Coincubation of 10 ng/mL
bFGF with 2 g/mL C3 produced similar effects as C3 alone, except cell lengths appeared to be longer. Bar, 25 m.
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tion of microtubules in cells at the wound edge 3 hours
after wounding. Controls had long acetylated -tubulin
processes extending from the centrosome to the posterior
cell border (Fig 6, A). C3-treated cultures (Fig 6, B), in
addition to actin microfilament loss, had a significant de-
crease in the percentage of cells at the wound edge with
long acetylated -tubulin processes (32.2%  4.5% of cells
for 2 g/mL C3 versus 84.2%  2.5% of cells for control)
when compared with control. Instead, acetylated -tubulin
was concentrated at the centrosome.
Addition of bFGF with C3 resulted in the reappearance
of acetylated -tubulin processes extending from the cen-
trosome to the posterior cell border (Fig 6, C), such that a
significant increase in the percentage of cells at the wound
edge with long acetylated -tubulin processes (55.7% 
2.8% of cells for 10 ng/mL bFGF  C3 versus 32.2% 
4.5% of cells for 2 g/mL C3) was seen when compared
with C3-treated cultures.
DISCUSSION
Rho inhibition with C3 caused a reduction in centro-
some redistribution to the front of the cell, loss of central
microfilaments, and decreased cell elongation after endo-
thelial wounding (Table). bFGF restored centrosome re-
distribution, cell elongation, and wound closure in the
presence of Rho inhibition. The Rho-independent bFGF-
induced centrosome redistribution may be an alternate
Fig 3. Confocal photomicrographs of control (A,B) and 2 g/mL C3-treated (C,D) endothelial cells at wound edge
3 hours after wounding double-stained for F-actin (red) and phosphotyrosine (green; A,C) or F-actin (red) and paxillin
(green; B,D). Wound is at top. In control cells, phosphotyrosine (A) and paxillin (B) localized at ends of central
microfilaments parallel to wound edge and at tips of filopodia. In C3-treated cells, central microfilament loss was
associated with reduction of both phosphotyrosine (C) and paxillin (D). However, phosphotyrosine was still seen at
ends of filopodia extending into wound and laterally (C). Bar, 25 m.
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process that ensures endothelial wound repair does occur,
although at a reduced efficiency.
Our results extend the findings16 that showed that Rho
inhibition with C3, a widely used specific inhibitor of Rho
A, B, and C activity,12,19 resulted in the loss of microfila-
ments and decreased human umbilical vein endothelial cell
migration 12 hours after wounding. We studied early
events and focused on changes to the centrosome redistri-
bution/microtubule cytoskeleton, to cell length, and to
focal adhesion sites that have been associated with
Rho.20-22
During early endothelial repair, RhoA staining was
concentrated with the randomly distributed centrosome
and alongside some microtubules in a punctate pattern.
Because RhoA did not colocalize with the microtubule
cytoskeleton throughout the cell, it suggested a loose cy-
toskeletal structural association between the two. However,
the literature does suggest a role for Rho in microtubule-
dependent intracellular transport. Kinectin, an anchoring pro-
tein of the microtubule motor protein kinesin, interacts with
Rho,23 and the Rho GEFs Lfc and GEF-H1 localize with
microtubules.24,25 Inhibition of RhoA activity inhibits glu-
cose transport and glucose transporter-4 vesicle membrane
translocation in rat adipocytes26 and disrupts endocytic traffic
of the polymeric immunoglobin receptor-IgA protein com-
plex in Madin-Darby canine kidney cells.27 It is interesting to
speculate that perhaps Rho or Rho GEFs or both may be
delivered along microtubules to vinculin-containing adhesion
sites28 for actin polymerization. This is consistent with the
findings that microtubules associate and release a factor that
induces actin stress fiber and focal adhesion formation.29
Perhaps the observation of Rho activation when microtubules
Fig 4. Confocal photomicrographs of control (A), bFGF-treated (B), C3-treated (C), or bFGF with C3-treated (D)
endothelial cells at wound edge 3 hours after wounding stained for -tubulin (see Fig 1, B). Wound is at top. Control cells
(A) and 10 ng/mL bFGF-treated cells (B) had centrosome redistribution to front of cell towards wound. C, C3 treatment
(2 g/mL) did not result in microtubule loss but did inhibit centrosome redistribution towards wound. D, Coincubation
of 10 ng/mL bFGF with 2 g/mL C3 restored centrosome redistribution towards wound and increased cell lengths.
Centrosome is identified as brightly stained amorphous area of tubulin (arrow) near nucleus (N). Bar, 25 m.
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are highly disrupted and depolymerized30 may be the result of
the release of sequestered Rho from the microtubules on
which they are transported. Because microtubules are highly
dynamic during cell elongation, the cytoplasmic staining of
RhoA in polymerized microtubule-free areas (Fig 6, B) may
indicate that RhoA was recently delivered to form focal
adhesion complexes that are no longer interacting with
microtubules.
In wounded endothelial monolayers treated with C3, the
less defined and slightly fragmented staining of microtubules
was associated with reduced centrosome redistribution and
decreased cell elongation. Rho activity has been shown to
selectively stabilize microtubules.15 In our Rho inhibition
experiments, C3 resulted in the loss of the normally seen
acetylated -tubulin processes that extend from the centro-
some to the posterior cell border. We suggest RhoA activity
may regulate centrosome redistribution, and subsequent cell
elongation and wound closure, with stabilization of microtu-
bules during early repair. These stable acetylated tubulin pro-
cesses may contribute to the force generation or aid in centro-
some redistribution. In addition, centrosome redistribution in
T cells and Golgi apparatus reorientation in primary rat em-
Fig 5. Confocal magnified photomicrographs of control endothelial cells in confluent monolayer (A) and at wound
edge (B) and of endothelial cells at wound edge treated with 2 g/mL C3 (C) or cotreated with 10 ng/mL bFGF and
2g/mL C3 (D) 3 hours after wounding. Endothelial cells were double-stained for RhoA (red) and -tubulin (green).
Wound is at top. A, In confluent monolayer, punctate RhoA staining was concentrated with centrosome and alongside
microtubules. B, After wounding, RhoA was concentrated with redistributed centrosome and alongside some
microtubules that radiated outwards from centrosome. C, Addition of C3 resulted in RhoA localization with less
defined and slightly fragmented microtubules and with nonredistributed centrosome. Note that C3 resulted in less
RhoA staining in areas devoid of polymerized microtubules (C, arrow) when compared with control wound edge
cells but that RhoA was seen in areas of highly disrupted microtubules (C, arrowhead). D, Coincubation of bFGF with
C3 restored centrosome redistribution towards wound. RhoA localized with redistributed centrosome and along
microtubules. Centrosome (c) is identified as brightly stained amorphous area of -tubulin near nucleus (N). Bars,
5 m.
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bryo fibroblast cells involve Rho family member, Cdc42.31,32
Cdc42 can activate Rho downstream.12 Thus, Cdc42’s ability
to regulate Golgi apparatus reorientation may occur via a
downstream Rho-signaling pathway.
bFGF-induced centrosome redistribution independent
of Rho activity was associated with the reappearance of
acetylated -tubulin processes. Thus, centrosome redistri-
bution may occur via a Rho-dependent pathway and a
bFGF-induced Rho-independent pathway, with both path-
ways resulting in the acetylation and subsequent stabiliza-
tion of microtubules. bFGF has been shown to stabilize
microtubule-based neural outgrowths with inducing post-
translational modification of the microtubule cytoskele-
ton.33 bFGF can also induce tyrosine phosphorylation of
the microtubule-associated protein Tau.34 Tau, like all
microtubule-associated proteins, stabilizes microtubules.
Fig 6. Confocal photomicrographs of control (A), C3-treated (B), or bFGF with C3-treated (C) endothelial cells at
wound edge 3 hours after wounding double-stained for F-actin (red) and acetylated -tubulin (green). Wound is at top.
A, Control cells exhibited long acetylated -tubulin processes extending from centrosome to posterior cell border
(arrowhead). B, C3 treatment (2 g/mL) resulted in loss of long acetylated -tubulin processes associated with
decreased cell elongation and inhibition of centrosome redistribution. C, Coincubation of 10 ng/mL bFGF with 2
g/mL C3 restored long acetylated -tubulin processes extending from centrosome to posterior cell border
(arrowhead) and increased cell elongation and centrosome redistribution. Acetylated -tubulin tended to concentrate
with centrosome near nucleus (N). Bar, 25 m.
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Perhaps in endothelial cells, bFGF may stabilize and acety-
late microtubules via phosphorylation of microtubule-asso-
ciated proteins in a Rho-independent manner.
bFGF is critical for both centrosome redistribution
towards the wound8 and for microfilament bundle reorga-
nization perpendicular to the wound edge (stage III).5
Because the inhibition of Rho does not prevent bFGF-
induced centrosome redistribution but does prevent micro-
filament bundle reorganization, bFGF may also act inde-
pendently of Rho in the former, and in the latter, bFGF
may activate Rho to regulate microfilament bundles and
focal adhesions. This is supported with the findings that
actin depolymerization with cytochalasin B does not affect
centrosome redistribution or microtubule polymerization
during endothelial wound repair.6
Endothelial migration in response to bFGF may be
mediated by a G protein-coupled receptor.35 However, the
exact signaling pathway/mechanism is not known. G pro-
teins have been shown to bind tubulin.36 In addition, G
protein G12 and G13 have been shown to modulate
Rho activity through interaction with p115 RhoGEF37 and
to mediate Rho/Rho kinase-dependent regulation of my-
osin light chain phosphorylation.38 G13 is able to activate
Rho in response to signaling from the lysophosphatidic acid
receptor via epidermal growth factor receptor.39 The re-
lease of endogenous bFGF after endothelial wounding8,40
may activate Rho through a similar G protein-coupled
receptor mechanism. Once activated, Rho may mediate
centrosome redistribution and actin central microfilament
bundle reorganization. If Rho is not activated downstream,
bFGF can alternatively carry out centrosome redistribution
and wound repair through an alternate Rho-independent
process.
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